Skip to main content
OpenTrials
Completed

NCT Number: NCT05806489

Glycemic Variability in Intermittent Fasting

The aim was to test the difference in glycemic variability after meal consumption during intermittent fasting and the usual diet.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Food and Nutrition Research, Faculty of Food Technology

Osijek, 31000, Croatia

About this study

Healthy participants were recruited for this crossover study aiming to determine the difference in glycemic variability after meal consumption while practicing intermittent fasting and the usual diet. Prior to the protocol assignment, participants were followed for 3 days - they were instructed to maintain their usual sleep pattern, level of physical activity and diet. Control of dietary pattern was conducted by using the 3-day food diary. Day zero was preparation day for the protocol (Intermittent fasting or Control diet) when all participants received individualized 3-day diet plan. Each protocol lasted 3 days with a 7-day washout period. Each protocol consisted of 3 meals per day, each providing a third of the total energy requirement. Control diet protocol was set at 12 hours eating/12 hours fasting, and Intermittent fasting protocol 6 hours eating/18 hours fasting. Blood glucose was measured at zero, 15, 30, 45 and 90 minutes after meal consumption. Before breakfast, blood glucose was measured also at minus 5 minutes prior meal consumption.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Body Mass Index in the range between 18.5 and 29.9 kg/m^2
  • stable sleep pattern (going to bed between 21:30h and midnight)
  • for women: regular menstrual cycle lasting between 21 and 35 days, with average bleeding time 2 to 6 days

Exclusion criteria

  • Body Mass Index below 18.5 or above 29.9 kg/m^2
  • irregular sleeping pattern
  • work in nightshift
  • high intensity workout routine
  • irregular dietary patterns (e.g. skipping meals)
  • regularly fasting for more than 15 hours per day
  • diagnosis of diabetes (or other conditions related to glycemic disorders)
  • hypertension or other cardiovascular disease
  • neurologic conditions
  • disease affecting metabolism (like liver, kidney, thyroid or lung)
  • use of medications for glycemia, hypertension, steroids, adrenergic stimulators, laxatives or supplements affecting glycemia, circadian rhythm, sleep or metabolism in general

Treatment and study plan

intermittent fasting

Other

Participants received a 3-day individualized diet plan consisting of 3 meals per day. Meals needed to be consumed during 6 hours (while fasting for the remaining 18 hours). Diet plans were matched for energy and macronutrients.

Control diet

Other

Participants received a 3-day individualized diet plan consisting of 3 meals per day. Meals needed to be consumed during 12 hours (while fasting for the remaining 12 hours). Diet plans were matched for energy and macronutrients.

Primary outcomes

  1. Blood glucose

    Time frame: 3 days per protocol

    Change in blood glucose

  2. Glycemic variability

    Time frame: 3 days per protocol

    Coefficient of Variation expressed as the ratio between standard deviation and mean blood glucose

Sponsors and collaborators

Lead sponsor

Josip Juraj Strossmayer University of Osijek

Other

Registry information

Official study title

Effect of Intermittent Fasting on Glycaemic Variability in Healthy Subjects

Acronym: GLUInterm

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Apr 10, 2023
Registry last updated
Apr 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.